Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2012-09, Vol.11 (9), p.730-730
Hauptverfasser:	Orchard, Sandra, Al-Lazikani, Bissan, Bryant, Steve, Clark, Dominic, Calder, Elizabeth, Dix, Ian, Engkvist, Ola, Forster, Mark, Gaulton, Anna, Gilson, Michael, Glen, Robert, Grigorov, Martin, Hammond-Kosack, Kim, Harland, Lee, Hopkins, Andrew, Larminie, Christopher, Lynch, Nick, Mann, Romeena K., Murray-Rust, Peter, Piparo, Elena Lo, Southan, Christopher, Steinbeck, Christoph, Wishart, David, Hermjakob, Henning, Overington, John, Thornton, Janet
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/309 706/648/453 706/648/479 92 Biomedical and Life Sciences Biomedicine Biotechnology Cancer Research Medicinal Chemistry Molecular Medicine Pharmaceutical research Pharmacology/Toxicology reply
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!